In 2019, there were around 23.6 million new cancer cases and approximately 10 million deaths globally, a 26.3% increase from the previous year. The rise of COVID-19 has had a devastating effect on the lives of cancer patients. Due to the limited resources available to treat the disease, many patients have had their diagnoses delayed. 

As the pandemic has started to subside, global communities are re-prioritizing the quality of cancer care and treatment. Here are the latest innovations revolutionizing cancer treatment.

Precision Oncology

The development of precision medicine is a new approach to treating cancer. Genetic sequencing, which can identify genetic variations in the body, can guide the treatment and diagnosis of patients.

The development of precision medicine is a new weapon for both patients and doctors. It can help them improve the quality of their lives by reducing the time it takes to diagnose and treat cancer.

Artificial Intelligence

Through AI, risk profiling can be performed on patients to identify potential cancer cases. It can also analyze X-rays to determine cancer in individuals who might not have the necessary resources.

AI is expected to play a vital role in reducing the burden of cancer in the population with poor access to high-quality care. It can also help pave the way for the development of AI-based technologies that can improve the efficiency of healthcare.

Biopsy Methodology

Currently, the primary method of diagnosing cancer is by performing a biopsy, which involves removing a portion of the body. However, this procedure is usually performed on a surgical basis. A liquid biopsy is a less invasive method that can be used for testing blood samples for signs of the disease. Another innovation that can be used for this is a synthetic biopsy, which can force cancer cells to self-destruct.

CAR-T-cell therapy

A new treatment for patients with leukemia called CAR-T-cell therapy has been shown to stimulate the body’s immune system to hunt down and kill cancer cells. This method involves removing and altering the genetically modified T cells from patients. These modified cells then produce specific proteins known as CARs, which can destroy cancer cells.

DNA Examination

According to scientists at Cambridge University Hospitals, the data collected from 12,000 patients’ cancer cells has revealed new information about the causes of the disease. Through the analysis of genetic information, doctors can identify the various mutations that contribute to the development of the disease—for instance, exposure to smoking or UV light or internal malfunctions in cells.